CVS Caremark removed Zepbound from Standard, Advanced, and Value formularies on July 1, 2025 (Wegovy is the preferred obesity GLP-1)
INDICATION AND SAFETY SUMMARY WITH WARNINGS Zepbound (ZEHP-bownd) is an injectable prescription medicine that may help adults with obesity, or with excess weight (overweight) who also have weight-related medical problems, lose weight and keep it off
The slower speed, which causes the stomach to empty more gradually, and generally eating less food can possibly give less beneficial gas-causing bacteria too much time to grow, adds nutritionist and author of The Small Change Diet , Keri Gans, RDN
Healthcare professionals should be aware of this potential side effect while prescribing semaglutide for patients with type 2 diabetes or obesity
Direct GLP-1-mediated suppression of joint inflammation has been suggested by preclinical models but not demonstrated in human RA patients taking tirzepatide
The subscription auto-renews, so forgetting to cancel before the renewal date means you will be charged for another period
